Charles Schwab’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Charles Schwab’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-50,844	Closed	-$877K	–	3291
2019 Q1	$877K	Hold	50,844	–	–	﹤0.01%	2590
2018 Q4	$650K	Buy	50,844 +3,144	+7%	+$47.7K	﹤0.01%	2671
2018 Q3	$775K	Hold	47,700	–	–	﹤0.01%	2701
2018 Q2	$615K	Hold	47,700	–	–	﹤0.01%	2733
2018 Q1	$594K	Buy	47,700 +7,200	+18%	+$87.6K	﹤0.01%	2687
2017 Q4	$566K	Hold	40,500	–	–	﹤0.01%	2695
2017 Q3	$681K	Hold	40,500	–	–	﹤0.01%	2627
2017 Q2	$682K	Hold	40,500	–	–	﹤0.01%	2591
2017 Q1	$628K	Hold	40,500	–	–	﹤0.01%	2571
2016 Q4	$606K	Buy	40,500 +11,100	+38%	+$156K	﹤0.01%	2594
2016 Q3	$370K	Hold	29,400	–	–	﹤0.01%	2722
2016 Q2	$265K	Hold	29,400	–	–	﹤0.01%	2828
2016 Q1	$292K	Hold	29,400	–	–	﹤0.01%	2786
2015 Q4	$339K	Hold	29,400	–	–	﹤0.01%	2818
2015 Q3	$397K	Hold	29,400	–	–	﹤0.01%	2716
2015 Q2	$408K	Hold	29,400	–	–	﹤0.01%	2756
2015 Q1	$414K	Buy	29,400 +10,300	+54%	+$140K	﹤0.01%	2698
2014 Q4	$261K	Hold	19,100	–	–	﹤0.01%	2903
2014 Q3	$292K	Hold	19,100	–	–	﹤0.01%	2810
2014 Q2	$322K	Buy	+19,100	New	+$344K	﹤0.01%	2827

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Charles Schwab's OXFD Position: Q2 2019 in Review

Charles Schwab sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2019, closing a stake of 50,844 shares — an estimated $877K sold.

Charles Schwab first reported a position in OXFD in Q2 2014 and held it in 20 quarters. The position peaked at $877K in Q1 2019. 86 funds tracked by Wall St. Rank hold OXFD as of Q2 2019.

Charles Schwab reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2019 after selling out during the quarter.
Charles Schwab sold 50,844 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2019, an estimated $877K.
Charles Schwab first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2014 and held it in 20 quarters.
Charles Schwab's Oxford Immunotec Global PLC Ordinary Shares position peaked at $877K in Q1 2019.
86 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2019.

Based on Charles Schwab's 13F filing for Q2 2019, filed 9 Aug 2019.